rs121434518
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_015474.4(SAMHD1):c.445C>T(p.Gln149*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. Q149Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015474.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Aicardi-Goutieres syndrome 5Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- Moyamoya diseaseInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- Aicardi-Goutieres syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial chilblain lupusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- chilblain lupus 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- chilblain lupusInheritance: AD Classification: NO_KNOWN Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SAMHD1 | NM_015474.4 | c.445C>T | p.Gln149* | stop_gained | Exon 4 of 16 | ENST00000646673.2 | NP_056289.2 | |
| SAMHD1 | NM_001363729.2 | c.445C>T | p.Gln149* | stop_gained | Exon 4 of 15 | NP_001350658.1 | ||
| SAMHD1 | NM_001363733.2 | c.445C>T | p.Gln149* | stop_gained | Exon 4 of 16 | NP_001350662.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461788Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727210 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Aicardi-Goutieres syndrome 5 Pathogenic:2Other:1
- -
Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this premature translational stop signal affects SAMHD1 function (PMID: 19525956, 22461318). This sequence change creates a premature translational stop signal (p.Gln149*) in the SAMHD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SAMHD1 are known to be pathogenic (PMID: 19525956, 22461318). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Aicardi-Goutieres syndrome (PMID: 19525956). ClinVar contains an entry for this variant (Variation ID: 4070). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at